ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Bombardier Inc

Bombardier Inc (BBD.PR.D)

19.49
0.00
(0.00%)
Closed February 20 04:12PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
19.49
Bid
19.10
Ask
19.50
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
19.49
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
95,488,749
Dividend Yield
-
PE Ratio
0.98
Earnings Per Share (EPS)
4.34
Revenue
8.05B
Net Profit
414M

About Bombardier Inc

Sector
Aircraft Engine,engine Parts
Industry
Indl,comml Machy,computer Eq
Headquarters
Dorval, Quebec, Can
Founded
1902
Bombardier Inc is listed in the Aircraft Engine,engine Parts sector of the Toronto Stock Exchange with ticker BBD.PR.D. The last closing price for Bombardier was $19.49. Over the last year, Bombardier shares have traded in a share price range of $ 0.00 to $ 0.00.

Bombardier currently has 95,488,749 shares outstanding. The market capitalization of Bombardier is $406.78 million. Bombardier has a price to earnings ratio (PE ratio) of 0.98.

BBD.PR.D Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CPOPPop Culture Group Company Ltd
$ 7.0301
(165.29%)
70.69M
MEDSTRxADE Health Inc
$ 8.96
(95.21%)
12.42M
MNPRMonopar Therapeutics Inc
$ 0.663
(93.52%)
100.22M
AVGRAvinger Inc
$ 5.4488
(83.15%)
461.11k
VINCVincerx Inc
$ 3.0895
(70.69%)
12.53M
HOLOMicroCloud Hologram Inc
$ 16.4551
(-75.20%)
11.38M
COOCooper Companies Inc
$ 95.76
(-74.26%)
1.3M
RAPTRAPT Therapeutics Inc
$ 6.865
(-73.57%)
13.97M
SIENSientra Inc
$ 0.2145
(-29.39%)
4.16M
UPCUniverse Pharmaceuticals Inc
$ 1.76
(-28.46%)
140.94k
NKLANikola Corporation
$ 0.7093
(-4.14%)
174.32M
SQQQProShares UltraPro Short QQQ
$ 11.92
(2.32%)
147.26M
AGRIAgriFORCE Growing Systems Ltd
$ 0.258
(20.56%)
119.63M
CISOCISO Global Inc
$ 0.1442
(44.20%)
114.8M
TSLATesla Inc
$ 193.76
(-3.10%)
104.53M

Discussion

View Full Feed
 just Scottie just Scottie 2 minutes ago
The new ceo

SpotOn Financial is a premier financial services brokerage located at the base of Pikes Peak, in Colorado Springs, Colorado. Although local to Colorado Springs, SpotOn Financial has a diverse client base located throughout the United States and Canada. The company special
GEGI
JoshTaeger JoshTaeger 2 minutes ago
No revenue, no size distribution, no mortality data. A whole lot of nothing. But that's the OTC, so I don't fault GRSP.

I hope they can string together more PRs that suggest...without actually having to prove...that they are selling shrimp. That way, the pps goes up and I can flip thi
GRPS
Thehustle Thehustle 2 minutes ago
It doesn’t matter how great the company is, if there is no buying pressure or stock awareness they will continue to drop it with a minimum amount of shares. Twitter sucks and it shouldn’t be the source of information. Company needs to figure out how to bring in the big kahunas. Kate has been on Nati
CEOS
marcis marcis 4 minutes ago
Again you are making a fool of yourself.

I wasn’t the fool who kept telling everyone it’s over and any moment delisted as early as August 2021 you kept telling everyone that BS

What is the share price? Today
Why does MM NITE have an ask over $1 now
Why l
HOMU
PickStocks PickStocks 4 minutes ago
15 years and you still have no clue….where is the money
COOP
hyperopia hyperopia 4 minutes ago
ski, I’ve admittedly not followed Roche closely, but I’m aware that they are a powerhouse in oncology, and have been the top seller of cancer drugs for years. Their older blockbusters, Rituxan, Herceptin and Avastin, etc., are going to be facing increasing competition from biosimilars just coming o
NWBO
powerbattles powerbattles 4 minutes ago
Yes, my scan picks up based on the volume spike right near the market close, so I jump in for a trade. I bought it at .128 and held it overnight.
IVP
BoscoLives21 BoscoLives21 4 minutes ago
Heeheeheehohohawhahahaha! That’s a stretch! Talk about $KEGS, bro
$$$$$$$$$$$$$$$$KEGS$$$$$$$$$$$$$$$$
KEGS
gfp927z gfp927z 5 minutes ago
Bar, Here's a summary of some of Berkshire's recent buy / sell activities (link below). It isn't meant to be all inclusive, but merely summarizes Berkshire's portfolio changes as outlined in various financial articles. I'm going to try to at least keep up with the changes in each new quarter.
MSFT
Manspider Manspider 5 minutes ago
Possibilities are always possible in the impossible OTC! Bring it!!! :-D
GTCH
Cosa Cosa 5 minutes ago
I'm hoping they manipulate the price down to $0.80 or lower. This stock is a winner long term.
MCRB
crazy horse 0 crazy horse 0 5 minutes ago
Yes we were right

Darn, only allowed me to read a minute's worth because I don't have an account.

We were right on all counts, CH

Blood clots, neurological disorders, and swollen hearts: Multinational study on COVID vaccines paints a damning picture
brooktrail1933 brooktrail1933 5 minutes ago
The vast majority of "pre-revenue" buyouts are with companies with products far less mature than ours. We have completed Phase 3 with first approval in the offing very soon. This is not a good comparison. I think BB may have slipped some info inadvertently (all my opinion and only my opinion) a w
NWBO
KCCO7913 KCCO7913 5 minutes ago
RIP to Terry Hallinan. He's one I wish I got to know better. One of the most fascinating characters I've ever come across.

Gates was so close to seeing this through.

Pit is still alive.

I'm sure there's more and more to come.
LWLG
Ecomike Ecomike 5 minutes ago
I do believe they had already filed / submitted that patent application for Absorbezz in late 2013, including the required sworn statements to the US Patent office, claiming (before the 2016 IFUS counter suit was filed against those two and Absorbezz):

1) It had not been introduced in
IFUS
randomwalk007 randomwalk007 6 minutes ago
At this point, everyone here is a loser irrespective of what side you take.
BrownRickRoss BrownRickRoss 7 minutes ago
Nixon better not become a fugitive under any circumstance because the WCVC Tommie Lee Jones (aka YOU!) will find him! 🔍🕵️‍♂️
delerious1 delerious1 7 minutes ago
Shows how messed up some of our stock advisors are here suggesting that shareholders should call the SEC? to get this and all GS stocks halted....like I would do that to myself....they obviously have never traded stocks, otherwise why on earh would I call the SEC to get my holdings halted....some of
GVSI
sspalmo sspalmo 7 minutes ago
Do they have the patent, or not? Did you mean to say Intellectual Property? If they applied for the patent, it is my understanding that they are protected unless a legitimate challenge to what they have filed is brought forward.

"Post#195001"
ENZC
teecee56 teecee56 7 minutes ago
my guess is vegas split town...a week or two ago
IDCC
janice shell janice shell 8 minutes ago
Thanks.
CYDY
mrplmer mrplmer 8 minutes ago
These guys report tomorrow. I know what I'd like the. to announce.

Nvidia (NVDA) will announce its fourth quarter earnings after the bell on Wednesday, one of the most highly anticipated earnings reports in recent memory. Shares of the AI chip darling have skyrocketed 184% over the la
AMD INTC NVDA
Truth and Transparency Truth and Transparency 8 minutes ago
Hearing this makes me sick. Mark needs to address shareholders ASAP.
NB
uptick1000 uptick1000 8 minutes ago
I see the picture...can YOU???
https://twitter.com/JohnLove2023/status/1760101246487155155
GMPR
uptick1000 uptick1000 9 minutes ago
someone else with innocent eyes is seeing the play book...

https://twitter.com/JohnLove2023/status/1760106546157982116
GMPR

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com